Search Results

A randomized trial of low versus moderate exposure busulfan for infants with severe combined immunodeficiency (SCID) receiving TCRαβ+/CD19+ depleted transplantation: A Phase II study by the Primary Immune Deficiency Treatment Consortium (PID-STUDY00002451

Busulfan exposure-finding for SCID with TCRαβ+/CD19+ depleted transplantation

PE298SO Outpatient EEG Tests - Somali

Outpatient EEG Tests / Somali Baaritaannada EEG ee Bukaansocodka Buug-yarahan wuxuu sharaxayaa baaritaanka EC gee bukaan-socodka, waxa la filan karo,...

PE3638 Tucking

Tucking For gender diverse youth and young adults This handout explains tucking, how to do it safely, and the risks and benefits. You get to decide...

Seattle Children's Hospital Providers Transplant Hope to One 3-Year-Ol

For more than three years, Destiny Smith’s routine consisted of daily intravenous nutrition, frequent trips to Seattle Children’s Hospital, about a...

Sadaf T Bhutta, MD

Sadaf T Bhutta, MD, Associate Professor

Pilot Protocol to Assess Device Acceptability-STUDY00001826

To learn more about this study, please email the study team member listed below.

PE2132 Psychologists and Therapists Specializing in Autism-Related Disorders

Psychologists and Therapists Specializing in Autism-Related Disorders If you find any of this information inaccurate or out of date, please contact...

Seattle Children’s MyChart

Information about how to use MySeattleChildrens and MyChart – Schedule and Pay.

Commitment to Health Equity and Anti-Racism

Learn about Seattle Children’s commitment to becoming an anti-racist and equitable health organization.

Jesse Lee Wenger, MD

Jesse Lee Wenger, MD, Assistant Professor